Literature DB >> 7296591

Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.

J S Millar, E M Williams.   

Abstract

Alinidine, a new compound which reduces heart rate in man and animals, has a selective action on the sinus node. The dose-response relation between alinidine and frequency is not altered by atropine, and alinidine does not block the positive chronotropic action of isoprenaline. Alinidine has no negative inotropic action and has no effect on the linear relation between extracellular Ca and force of myocardial contraction. Alinidine did not alter the slope of the relation between frequency and external calcium concentration. Intracellular recordings showed that alinidine had no effect on the maximum rate of depolarisation or overshoot potential of rabbit atrial muscle, nor was conduction velocity, electrical threshold or maximum follow frequency affected. It was concluded that alinidine did not restrict current through fast inward channels. Alinidine did not increase resting potential or accelerate repolarisation, suggesting that potassium conductance was not increased. The effect of alinidine on frequency was not increased in 14 mmol . litre-1 KCl, or decreased in 2.24 mmol . litre-1 KCl, suggesting that the attachment of alinidine to receptors was not voltage-dependent. Spontaneous frequency was higher when NaCl was replaced by NaBr, and the bradycardic effect of alinidine was increased. Conversely, frequency was lower in NaCH3SO4 and the slope of the dose-response curve decreased. Intracellular recordings from sinus node cells showed that alinidine decreased the slope of the slow diastolic depolarisation and increased action potential duration, without altering the overshoot, the maximum diastolic potential, or the "take-off" potential. A possible explanation for these results is that alinidine restricts current through anion-selective channels. If so, the high potency of alinidine suggests that anionic current normally carries a substantial fraction of the current causing slow diastolic depolarisation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296591     DOI: 10.1093/cvr/15.6.335

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  18 in total

1.  The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion.

Authors:  L J van Woerkens; W J van der Giessen; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

2.  Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

Authors:  M Boucher; E Chapuy; M A Lefebvre; A Mignot; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

3.  Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

4.  Proceedings of the joint meeting of the Scandinavian and British Pharmacological Societies. Stockholm--Sweden. 5th and 6th July, 1982.

Authors: 
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

Review 5.  The funny current: cellular basis for the control of heart rate.

Authors:  Dario DiFrancesco; Jeffrey S Borer
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.

Authors:  J S Millar; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

7.  Alinidine modifies the pacemaker current in sheep Purkinje fibers.

Authors:  D J Snyders; P P Van Bogaert
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

8.  Interactions between alinidine and responses to acetylcholine, dopamine and 5-hydroxytryptamine of specific Helix central neurones.

Authors:  A J Bokisch; R J Walker
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  Safety and efficacy of alinidine in symptom-free asthmatics.

Authors:  J Lichey; M Hoffmann; H Huckauf; G Kammradt; T Friedrich
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.

Authors:  C Lillie; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.